FDA rejects Merck's Vioxx successor (India Daily)
The Food and Drug Administration rejected Merck & Co.'s request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drugmaker said Friday. The move was widely expected, after a panel of FDA advisers two weeks ago voted 20-1 against approving the drug, Arcoxia.

Transcript of Tele-News Conference Regarding FDA-USDA Update on Recall of Pet Foods Washington D.C. April 26, 2007 (USDA)
MODERATOR: Thank you. Welcome, ladies and gentlemen. I'm Julie Zawisza, assistant commissioner for Public Affairs with the Food and Drug Administration.

PFab LP stops drug production following US FDA warning (PharmaBiz)
The US Food and Drug Administration (FDA) announced the entry of a consent decree of permanent injunction against PharmaFab Inc., its subsidiary, PFab LP, and two company officials, Mark Tengler, PharmaFab's president, and Russ McMahen, PFab's vice president of scientific affairs, to stop the illegal manufacture and distribution of prescription and over-the-counter drug products.